← Open Payments lookup

JAIME CANNON: Open Payments

NPI 1073894168 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,237 in 106 payments from 21 companies in 2025. Trend: 2023 $2,630 · 2024 $2,367 · 2025 $2,237

Food & beverage: $2,237
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP20$420
GlaxoSmithKline, LLC.15$264
Amgen Inc.15$225
GENZYME CORPORATION7$160
Regeneron Healthcare Solutions, Inc.7$141
United Therapeutics Corporation6$140
Grifols USA, LLC4$112
Viatris Specialty LLC5$110
Takeda Pharmaceuticals U.S.A., Inc.4$109
Pulmonx Corporation1$108

Products named: TEZSPIRE, DUPIXENT, FASENRA, NUCALA, Tyvaso, Prolastin-C Liquid, TRELEGY ELLIPTA, YUPELRI.

Industry payments across AL — which companies pay providers there.